Mark Ballantyne

Associate

I love the challenges of working with technology and life sciences companies as they evolve from startups to public companies.

mballantyne@cooley.com

Mark Ballantyne focuses his practice on representing IPO ready and publicly traded life sciences and technology companies, as well as underwriters.

Download full bio 

Experience

  • BigCommerce Holdings – $345 Million Convertible Senior Notes Offering 

  • Legend Biotech - $487 Million IPO 

  • LogicBio Therapeutics – $80.5 Million IPO 

  • Verrica Pharmaceuticals – $86 Million IPO 

  • Translate Bio – $122 Million IPO 

  • View all

Education

  • University of Richmond School of Law
    JD, magna cum laude, Order of the Coif, McNeill Law Society, 2012

  • Wake Forest University
    BA, 2008


Admissions & Credentials

Virginia

Rankings & Accolades

    Best Lawyers: Ones to Watch - Securities/Capital Markets Law and Venture Capital Law (2021)